Enfortumab vedotin-ejfv ka pahu kui

Anter

• Ma mua o ka loaʻa ʻana o ka enfortumab vedotin-ejfv injection,
• ʻO Enfortumab vedotin-ejfv injection ke kumu i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole kēlā mau mea i ka ʻĀKAHI MAKAHIKI ʻāpana, e kelepona koke i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia

Hoʻohana ʻia ʻo Enfortumab vedotin-ejfv injection e mālama ai i ka maʻi ʻaʻai urothelial (ka maʻi ʻaʻai o ka pale o ka maʻi ʻaʻai a me nā ʻāpana ʻē aʻe o ka maʻi kō. ʻO ka Enfortumab vedotin-ejfv injection i loko o ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ke kōkua ʻana i kāu ʻōnaehana pale e hoʻolohi a kū i ka ulu ʻana o nā hunaola maʻi ʻaʻai.

ʻO ka Enfortumab vedotin-ejfv injection i hele mai me he lepo lā e hui ʻia me ka wai a injected intravenously (i loko o kahi aa) ma mua o 30 mau minuke e ke kauka a kahu hānai paha i kahi haukapila a i ʻole kahi wahi olakino. Hoʻokomo pinepine ʻia ia i nā lā 1, 8, a me 15 o kahi pōʻaiapuni 28 mau lā no ka mea ke paipai ke kauka e loaʻa iā ʻoe ka lāʻau.

Hiki paha i kāu kauka ke hoʻolohi a hoʻopau paha i kāu lāʻau lapaʻau me ka enfortumab vedotin-ejfv injection, a i ʻole mālama iā ʻoe me nā lāʻau hou aʻe, kaukaʻi ʻia i kāu pane i ka lāʻau a me nā hopena ʻaoʻao āu e ʻike ai. E kamaʻilio me kāu kauka e pili ana i kou ʻano i kāu mālama ʻana.

E noi i kāu kauka lāʻau a kauka paha no kahi kope o ka ʻike a ka mea hana no ka mea maʻi.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka enfortumab vedotin-ejfv injection,

• e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka enfortumab vedotin-ejfv injection, kekahi lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka enfortumab vedotin-ejfv injection. E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. E haʻi pono i kekahi o kēia mau mea: clarithromycin (Biaxin); idelalisib (Zydelig); indinavir (Crixivan); ketoconazole (Nizoral); nefazodone; nelfinavir (Viracept); ritonavir (Norvir, ma Kaletra); aiʻole saquinavir (Invirase). Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole loaʻa iā ʻoe kahi neuropathy ākea (kahi ʻano o ke ʻāʻeha o ke aʻalolo e hoʻonāukiuki ai, numbness, a me ka ʻeha ma nā lima a me nā wāwae), diabetes a i ʻole ke kō kō, a i ʻole nā ​​maʻi ate.
• E haʻi i kāu kauka inā hāpai ʻoe, e hoʻolālā e hāpai, a inā ʻoe e hoʻolālā i kahi keiki i kahi keiki. ʻAʻole ʻoe a ʻo kāu hoa paha e hāpai i ka wā e loaʻa ana iā ʻoe ka enfortumab vedotin-ejfv injection. E hana paha kāu kauka i kahi hoʻokolohua hāpai keiki e ʻike pono ʻaʻole ʻoe i hāpai ma mua o ka loaʻa ʻana o ka enfortumab vedotin-ejfv injection. Inā he wahine ʻoe, pono ʻoe e hoʻohana i ka kaohi hānau ma kāu mālama ʻana a no 2 mau mahina ma hope o kāu hopena hope loa. Inā he kāne ʻoe, pono ʻoe a me kāu pakanā wahine e hoʻohana i ka kaohi hānau ma kāu wā e mālama ai a no 4 mau mahina ma hope o kāu hopena hope loa. E kamaʻilio me kāu kauka e pili ana i nā hana kaohi hānau e holo pono nāu. Inā hāpai ʻoe a ʻo kāu hoa paha i ka wā e loaʻa ana ka enfortumab vedotin-ejfv injection, e kāhea i kāu kauka. Hiki paha i ka Enfortumab vedotin-ejfv ke hōʻino i ka fetus.
• e haʻi i kāu kauka inā ʻoe e hānai umauma ana. ʻAʻole pono ʻoe e hānai i ka umauma ʻoiai e loaʻa ana iā ʻoe ka enfortumab vedotin-ejfv injection a no 3 mau pule ma hope o kāu hopena hope loa.
• pono ʻoe e ʻike i kēia lāʻau i hoʻemi ai i ka momona i nā kāne. E kamaʻilio me kāu kauka e pili ana i nā pilikia o ka loaʻa ʻana o ka enfortumab vedotin-ejfv injection.
• pono ʻoe e ʻike e ʻike paha ʻoe i ka hyperglycemia (hoʻonui i kāu kō kō) ʻoiai ke loaʻa nei iā ʻoe kēia lāʻau, ʻoiai inā ʻaʻohe ou diabetes. E haʻi koke i kāu kauka inā loaʻa iā ʻoe kekahi o kēia mau ʻōuli ke loaʻa iā ʻoe ka enfortumab vedotin-ejfv injection: make wai loa, mimiki pinepine, pōloli loa, ʻike maka ʻole, a nāwaliwali paha. He mea nui ia e kāhea aku i kāu kauka ke loaʻa koke iā ʻoe kekahi o kēia mau ʻōuli, no ka mea, ʻaʻole mālama ʻia ke kō koko kiʻekiʻe e mālama ʻia ai i kahi ʻano koʻikoʻi i kapa ʻia ʻo ketoacidosis. Lilo paha ʻo Ketoacidosis i mea hoʻoweliweli i ke ola ke mālama ʻole ʻia ia i ka wā mua. ʻO nā ʻōuli o ketoacidosis e komo pū me: waha maloʻo, nausea a me ka luaʻi, ka hanu o ka hanu, ka hanu e ʻaʻala i ka hua, a me ka emi o ka ʻike.
• pono ʻoe e ʻike he hiki i kēia lāʻau ke kumu i nā maka maloʻo a me nā pilikia maka ʻē aʻe, he koʻikoʻi paha. E haʻi paha kāu kauka iā ʻoe e hoʻohana i nā waimaka a i ʻole nā ​​lubricant maka kulu i kou wā e mālama ai me enfortumab vedotin-ejfv.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

ʻO Enfortumab vedotin-ejfv injection ke kumu i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• pāhoehoe
• ka luaʻi
• nausea
• nalo ʻai ʻole
• loli ka ʻono
• poho lauoho
• ʻili maloʻo

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole kēlā mau mea i ka ʻĀKAHI MAKAHIKI ʻāpana, e kelepona koke i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia

• pokole o ka hanu
• ʻili mae
• ʻākeʻakeʻa a ʻili ranei
• ʻulaʻula ʻula, pehu, wela, a ʻeha paha ma ka pūnaewele injection
• ʻike maka ʻole, nalowale o ka hihiʻo, ʻeha o ka maka a ʻulaʻula paha, a i ʻole nā ​​loli ʻike ʻike ʻē aʻe
• numbness, puhi ʻana, a i ʻole ka ʻūlū ʻana i nā lima a me nā wāwae paha
• nāwaliwali o nā mākala
• luhi nui loa a nele paha i ka ikaika

ʻO Enfortumab vedotin-ejfv injection ke kumu o nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha aku kāu kauka i kekahi mau hoʻokolohua lab e nānā i ka pane o kou kino i ka enfortumab vedotin-ejfv.

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka enfortumab vedotin-ejfv injection.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• Padcev^®